Company profile: XenoGesis
1.1 - Company Overview
Company description
- Provider of preclinical drug metabolism and pharmacokinetics (DMPK), quantitative bioanalysis, and expert interpretation as a specialised CRO.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to XenoGesis
Careform
HQ: United States
Website
- Description: Provider of technology-enabled hub services that drive patient and provider engagement and support, simplifying access to specialty pharmaceuticals through patient support services. BrandHub delivers inventory management, EHR integration, and therapy cycle management to identify and remove barriers to patient access, supported by logistics experts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Careform company profile →
Base Life Science
HQ: Denmark
Website
- Description: Provider of information technology consulting and solutions, including the BASE Migration Framework for complex, compliant data migrations; Veeva Development Cloud services for process strategy, implementation, training, and post-implementation support; clinical process optimization, system training and implementation (CDMS, eTMF, CTMS); and CRO onboarding and oversight.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Base Life Science company profile →
Cambrex
HQ: United States
Website
- Description: Provider of end-to-end small molecule drug substance and drug product development and manufacturing, analytical services and testing, IND-enabling services, and process development. Supports research through commercial scale, covering various dosage forms, streamlining IND submissions, and ensuring regulatory compliance and product safety for small molecule therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cambrex company profile →
Celerion
HQ: United States
Website
- Description: Provider of early clinical research and Applied Translational Medicine, translating research discoveries into knowledge of drug action in humans to support early development decisions. Services include bioanalytical sciences for small and large molecules; clinical development (safety, PK/PD); data management and biometrics; global drug development (regulatory, project management); EDC; and eTMF via secure, DIA-formatted portal.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Celerion company profile →
Labcorp
HQ: United States
Website
- Description: Provider of laboratory testing and drug development services for physicians and patients, hospitals, managed care plans, employers, military, law enforcement, and biopharmaceutical companies. Offerings include genetic and oncology testing, Alzheimer’s blood-based biomarkers (pTau-217, Beta Amyloid 42/40 Ratio), Labcorp OnDemand self-ordered tests, and biopharma services supported by a global laboratory network and clinical data resources.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Labcorp company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for XenoGesis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to XenoGesis
2.2 - Growth funds investing in similar companies to XenoGesis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for XenoGesis
4.2 - Public trading comparable groups for XenoGesis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →